+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 5flc | ||||||
---|---|---|---|---|---|---|---|
タイトル | Architecture of human mTOR Complex 1 - 5.9 Angstrom reconstruction | ||||||
![]() |
| ||||||
![]() | TRANSFERASE / RAPAMYCIN / MTORC1 | ||||||
機能・相同性 | ![]() RNA polymerase III type 2 promoter sequence-specific DNA binding / RNA polymerase III type 1 promoter sequence-specific DNA binding / positive regulation of cytoplasmic translational initiation / T-helper 1 cell lineage commitment / positive regulation of pentose-phosphate shunt / regulation of locomotor rhythm / positive regulation of wound healing, spreading of epidermal cells / TORC2 signaling / TORC2 complex / regulation of membrane permeability ...RNA polymerase III type 2 promoter sequence-specific DNA binding / RNA polymerase III type 1 promoter sequence-specific DNA binding / positive regulation of cytoplasmic translational initiation / T-helper 1 cell lineage commitment / positive regulation of pentose-phosphate shunt / regulation of locomotor rhythm / positive regulation of wound healing, spreading of epidermal cells / TORC2 signaling / TORC2 complex / regulation of membrane permeability / cellular response to leucine starvation / heart valve morphogenesis / negative regulation of lysosome organization / TFIIIC-class transcription factor complex binding / TORC1 complex / positive regulation of transcription of nucleolar large rRNA by RNA polymerase I / calcineurin-NFAT signaling cascade / voluntary musculoskeletal movement / regulation of osteoclast differentiation / RNA polymerase III type 3 promoter sequence-specific DNA binding / positive regulation of keratinocyte migration / regulation of lysosome organization / Amino acids regulate mTORC1 / cellular response to L-leucine / MTOR signalling / cellular response to nutrient / regulation of autophagosome assembly / Energy dependent regulation of mTOR by LKB1-AMPK / TORC1 signaling / energy reserve metabolic process / ruffle organization / serine/threonine protein kinase complex / negative regulation of cell size / cellular response to methionine / positive regulation of ubiquitin-dependent protein catabolic process / inositol hexakisphosphate binding / cellular response to osmotic stress / anoikis / negative regulation of protein localization to nucleus / cardiac muscle cell development / negative regulation of calcineurin-NFAT signaling cascade / regulation of myelination / positive regulation of transcription by RNA polymerase III / positive regulation of actin filament polymerization / negative regulation of macroautophagy / Macroautophagy / regulation of cell size / positive regulation of myotube differentiation / Constitutive Signaling by AKT1 E17K in Cancer / oligodendrocyte differentiation / germ cell development / behavioral response to pain / TOR signaling / mTORC1-mediated signalling / positive regulation of oligodendrocyte differentiation / positive regulation of translational initiation / CD28 dependent PI3K/Akt signaling / positive regulation of TOR signaling / response to amino acid / HSF1-dependent transactivation / regulation of macroautophagy / 'de novo' pyrimidine nucleobase biosynthetic process / cellular response to nutrient levels / vascular endothelial cell response to laminar fluid shear stress / neuronal action potential / positive regulation of lipid biosynthetic process / positive regulation of epithelial to mesenchymal transition / heart morphogenesis / regulation of cellular response to heat / positive regulation of lamellipodium assembly / cardiac muscle contraction / phagocytic vesicle / positive regulation of stress fiber assembly / T cell costimulation / cytoskeleton organization / endomembrane system / negative regulation of autophagy / cellular response to amino acid starvation / protein serine/threonine kinase activator activity / positive regulation of glycolytic process / cellular response to starvation / regulation of signal transduction by p53 class mediator / Regulation of PTEN gene transcription / post-embryonic development / positive regulation of translation / VEGFR2 mediated vascular permeability / TP53 Regulates Metabolic Genes / regulation of actin cytoskeleton organization / phosphoprotein binding / cellular response to amino acid stimulus / non-specific protein-tyrosine kinase / regulation of cell growth / macroautophagy / response to nutrient levels / regulation of circadian rhythm / protein destabilization / PML body / multicellular organism growth / cellular response to insulin stimulus / Regulation of TP53 Degradation 類似検索 - 分子機能 | ||||||
生物種 | ![]() ![]() ![]() | ||||||
手法 | 電子顕微鏡法 / 単粒子再構成法 / クライオ電子顕微鏡法 / 解像度: 5.9 Å | ||||||
![]() | Aylett, C.H.S. / Sauer, E. / Imseng, S. / Boehringer, D. / Hall, M.N. / Ban, N. / Maier, T. | ||||||
![]() | ![]() タイトル: Architecture of human mTOR complex 1. 著者: Christopher H S Aylett / Evelyn Sauer / Stefan Imseng / Daniel Boehringer / Michael N Hall / Nenad Ban / Timm Maier / ![]() 要旨: Target of rapamycin (TOR), a conserved protein kinase and central controller of cell growth, functions in two structurally and functionally distinct complexes: TORC1 and TORC2. Dysregulation of ...Target of rapamycin (TOR), a conserved protein kinase and central controller of cell growth, functions in two structurally and functionally distinct complexes: TORC1 and TORC2. Dysregulation of mammalian TOR (mTOR) signaling is implicated in pathologies that include diabetes, cancer, and neurodegeneration. We resolved the architecture of human mTORC1 (mTOR with subunits Raptor and mLST8) bound to FK506 binding protein (FKBP)-rapamycin, by combining cryo-electron microscopy at 5.9 angstrom resolution with crystallographic studies of Chaetomium thermophilum Raptor at 4.3 angstrom resolution. The structure explains how FKBP-rapamycin and architectural elements of mTORC1 limit access to the recessed active site. Consistent with a role in substrate recognition and delivery, the conserved amino-terminal domain of Raptor is juxtaposed to the kinase active site. | ||||||
履歴 |
|
-
構造の表示
ムービー |
![]() |
---|---|
構造ビューア | 分子: ![]() ![]() |
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 1016.8 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 817.7 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
---|
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
|
---|---|
1 |
|
-
要素
-SERINE/THREONINE-PROTEIN KINASE ... , 3種, 6分子 1324BF
#1: タンパク質 | 分子量: 52357.672 Da / 分子数: 2 / 断片: HORN DOMAIN / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() 発現宿主: ![]() ![]() 参照: non-specific serine/threonine protein kinase #2: タンパク質 | 分子量: 31081.197 Da / 分子数: 2 / 断片: BRIDGE DOMAIN / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() 発現宿主: ![]() ![]() 参照: non-specific serine/threonine protein kinase #4: タンパク質 | 分子量: 134036.641 Da / 分子数: 2 / 断片: FAT AND PIKK DOMAINS / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() 発現宿主: ![]() ![]() 参照: UniProt: P42345, non-specific serine/threonine protein kinase |
---|
-タンパク質 , 3種, 6分子 AECGDH
#3: タンパク質 | 分子量: 87589.977 Da / 分子数: 2 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() 発現宿主: ![]() ![]() #5: タンパク質 | 分子量: 9124.238 Da / 分子数: 2 / 由来タイプ: 天然 由来: (天然) ![]() ![]() #6: タンパク質 | 分子量: 35910.090 Da / 分子数: 2 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() 発現宿主: ![]() ![]() 参照: UniProt: Q9BVC4 |
---|
-非ポリマー , 1種, 2分子 
#7: 化合物 |
---|
-実験情報
-実験
実験 | 手法: 電子顕微鏡法 |
---|---|
EM実験 | 試料の集合状態: PARTICLE / 3次元再構成法: 単粒子再構成法 |
-
試料調製
構成要素 | 名称: HUMAN MTOR COMPLEX 1 / タイプ: COMPLEX |
---|---|
緩衝液 | 名称: 100 MM NACL, 10 MM NABICINE, 1 MM TCEP / pH: 8 / 詳細: 100 MM NACL, 10 MM NABICINE, 1 MM TCEP |
試料 | 包埋: NO / シャドウイング: NO / 染色: NO / 凍結: YES |
試料支持 | 詳細: CARBON |
急速凍結 | 装置: FEI VITROBOT MARK I / 凍結剤: ETHANE 詳細: VITRIFICATION 1 -- CRYOGEN- ETHANE, HUMIDITY- 100, TEMPERATURE- 120, INSTRUMENT- FEI VITROBOT MARK I, METHOD- 4 SECOND BLOTTING, |
-
電子顕微鏡撮影
実験機器 | ![]() モデル: Titan Krios / 画像提供: FEI Company |
---|---|
顕微鏡 | モデル: FEI TITAN KRIOS / 日付: 2015年5月5日 |
電子銃 | 電子線源: ![]() |
電子レンズ | モード: BRIGHT FIELD / 倍率(公称値): 59000 X / 倍率(補正後): 100719 X / 最大 デフォーカス(公称値): 4000 nm / 最小 デフォーカス(公称値): 1900 nm / Cs: 2.7 mm |
試料ホルダ | 温度: 100 K |
撮影 | 電子線照射量: 25 e/Å2 フィルム・検出器のモデル: FEI FALCON II (4k x 4k) |
-
解析
EMソフトウェア |
| ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CTF補正 | 詳細: EACH IMAGE | ||||||||||||||||
対称性 | 点対称性: C2 (2回回転対称) | ||||||||||||||||
3次元再構成 | 手法: MAXIMUM A POSTERIORI PROJECTION MATCHING / 解像度: 5.9 Å / 粒子像の数: 309792 / ピクセルサイズ(公称値): 1.39 Å / ピクセルサイズ(実測値): 1.39 Å 詳細: THE UNK CHAINS (A, E, C, G, 1-4) CORRESPONDING TO RAPTOR (A,E), SF FKBP AND RAPAMYCIN (C,G) AND THE N-TERMINAL HEAT REPEATS OF MTOR (1-4), HAVE BEEN NUMBERED FROM 100 AT EACH BREAK TO ...詳細: THE UNK CHAINS (A, E, C, G, 1-4) CORRESPONDING TO RAPTOR (A,E), SF FKBP AND RAPAMYCIN (C,G) AND THE N-TERMINAL HEAT REPEATS OF MTOR (1-4), HAVE BEEN NUMBERED FROM 100 AT EACH BREAK TO INDICATE LACK OF SEQUENCE - DENSITY CERTAINTY. CHAINS 1-4 CORRESPOND TO THE N-TERMINAL HEAT REPEAT DOMAINS OF MTOR. WE PROPOSE A TOPOLOGY IN THE CORRESPONDING PAPER (1-2-B AND 3-4-F), BUT GIVEN THE FACT THAT THEIR TOPOLOGY CANNOT BE ASSIGNED DEFINITIVELY THEY ARE REPRESENTED AS A SEPARATE CHAIN FOR EACH DOMAIN. THE FITTING OF CRYSTAL STRUCTURES FOR THE MTOR FAT AND PIKK DOMAINS, MLST8, RAPTOR AND FKBP ALLOWS THEIR DENSITY TO BE ASSIGNED DEFINITIVELY, AND THEIR CHAINS ARE THEREFORE LETTERED. SUBMISSION BASED ON EXPERIMENTAL DATA FROM EMDB EMD-3213. (DEPOSITION ID: 13912). 対称性のタイプ: POINT | ||||||||||||||||
原子モデル構築 | プロトコル: RIGID BODY FIT / Target criteria: FSC / 詳細: METHOD--RIGID BODY | ||||||||||||||||
精密化 | 最高解像度: 5.9 Å | ||||||||||||||||
精密化ステップ | サイクル: LAST / 最高解像度: 5.9 Å
|